Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05874596
Other study ID # OPTIMAL
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 22, 2023
Est. completion date September 1, 2024

Study information

Verified date April 2023
Source Second Affiliated Hospital, School of Medicine, Zhejiang University
Contact Min Lou, PhD
Phone +8613958007213
Email loumingxc@vip.sina.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A clustered randomized control trial to evaluate whether multi-aspect intervention based on an AI-aided clinical feedback system could improve the quality of EVT and functional outcome of patients.


Description:

Endovascular treatment (EVT) is the standard treatment for acute ischemic stroke (AIS) caused by large vessel occlusion (LVO) according to current guidelines. However, while a rapidly-growing number of stroke centers become capable of performing EVT, the general quality of EVT remains unsatisfied, resulting in a considerable proportion of patients who could not reach functional independence. Our pre-established artificial intelligence (AI)-aided clinical feedback system could dynamically record and report key timepoints of EVT in-hospital process. Combined with multi-aspect intervention via remote/on-site surveillance and education, this may be a potential solution for quality improvement of EVT. Therefore, the aim of the study is to evaluate whether an AI-aided clinical feedback system coupled with multi-aspect intervention could improve the quality of EVT. Twenty hospitals with annual EVT cases > 30 will be 1:1 randomized into intervention group and control group. The intervention group will receive AI-based clinical feedback system coupled with multi-aspect intervention, including remote/on-site surveillance and education regarding in-hospital workflow and surgical procedures of EVT. The control group only deploys AI-aided clinical feedback system. The primary outcome is the ratio of good functional outcome (mRS > 2) at 3 month.


Recruitment information / eligibility

Status Recruiting
Enrollment 1221
Est. completion date September 1, 2024
Est. primary completion date June 1, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age > 18 - AIS patients receiving EVT within 24 hours of stroke onset - Written informed consent is obtained Exclusion Criteria: - Patients refuse to participate in this study

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
AI-aided clinical feedback system coupled with multi-aspect intervention basd on Behaviour Change Wheel model
Interventions are developed on a psychological model, the Behaviour Change Wheel (BCW) .The fundamental of BCW consists of three essential elements: capability, motivation, and opportunity. Improving individual's capability, providing motivation, and increasing opportunities are goals of behaviour change intervention. To achieve the goals, 9 intervention components have been proposed in the BCW framework, and 6 components will be used in current study.

Locations

Country Name City State
China Second Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou

Sponsors (1)

Lead Sponsor Collaborator
Second Affiliated Hospital, School of Medicine, Zhejiang University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Other Ratio of favorable functional outcome at 3 month in patients within 6 hours of stroke onset Ratio of mRS > 2 at 3 month follow-up in patients within 6 hours of stroke onset 3 months
Other Door to groin puncture time in patients within 6 hours of stroke onset Time interval between admission and groin puncture in patients within 6 hours of stroke onset 24 hours
Primary Ratio of favorable functional outcome at 3 month Ratio of patients with mRS > 2 at 3-month follow up 3 months
Secondary Ratio of good functional outcome at 3 month Ratio of patients with mRS > 1 at 3-month follow up 3 months
Secondary mRS score at 3 month mRS score at 3-month follow up 3 months
Secondary Mortality at 3 month Mortality at 3-month follow up 3 months
Secondary Ratio of hemorrhagic transformation at 24 hour Ratio of hemorrhagic transformation at 24 hour after EVT 24 hours
Secondary Ratio of symptomatic intracranial hemorrhage at 24 hour Ratio of symptomatic intracranial hemorrhage at 24 hour after EVT 24 hours
Secondary Door to groin puncture time Time interval between admission and groin puncture 24 hours
Secondary Ratio of door to groin puncture time < 90 min Time interval between admission and groin puncture <90 min 24 hours
Secondary Ratio of door to groin puncture time < 60 min Time interval between admission and groin puncture <60 min 24 hours
Secondary Procedural duration Time interval between groin puncture and last time of digital subtraction angiography 24 hours
Secondary Ratio of successful reperfusion Ratio of patients achieving modified thrombolysis in cerebral infarction (mTICI) 2b or 3 24 hours
See also
  Status Clinical Trial Phase
Recruiting NCT05378035 - DOAC in Chinese Patients With Atrial Fibrillation
Completed NCT03574038 - Transcranial Direct Current Stimulation as a Neuroprotection in Acute Stroke N/A
Completed NCT03679637 - Tablet-based Aphasia Therapy in the Acute Phase After Stroke N/A
Completed NCT03633422 - Evaluation of Stroke Patient Screening
Completed NCT04088578 - VNS-supplemented Motor Retraining After Stroke N/A
Not yet recruiting NCT05534360 - Tenecteplase Treatment in Ischemic Stroke Registry
Withdrawn NCT04991038 - Clinical Investigation to Compare Safety and Efficacy of DAISE and Stent Retrievers for Thrombectomy In Acute Ischemic Stroke Patients N/A
Not yet recruiting NCT04105322 - Effects of Kinesio Taping on Balance and Functional Performance in Stroke Patients N/A
Withdrawn NCT05786170 - ERILs Und SNILs Unter SOC N/A
Recruiting NCT03132558 - Contrast Induced Acute Kidney in Patients With Acute Stroke N/A
Completed NCT02893631 - Assessment of Hemostasis Disorders in rtPA-treated Patients Requiring Endovascular Treatment for Ischemic Stroke
Active, not recruiting NCT02274727 - Biomarker Signature of Stroke Aetiology Study: The BIOSIGNAL-Study
Completed NCT02225730 - Imaging Collaterals in Acute Stroke (iCAS)
Terminated NCT01705353 - The Role of HMGB-1 in Chronic Stroke N/A
Active, not recruiting NCT01581502 - SAMURAI-NVAF Study: Anticoagulant Therapy for Japanese Stroke Patients With Nonvalvular Atrial Fibrillation (NVAF) N/A
Completed NCT01182818 - Fabry and Stroke Epidemiological Protocol (FASEP): Risk Factors In Ischemic Stroke Patients With Fabry Disease N/A
Completed NCT00761982 - Autologous Bone Marrow Stem Cells in Middle Cerebral Artery Acute Stroke Treatment. Phase 1/Phase 2
Completed NCT00535197 - Autologous Bone Marrow Stem Cells in Ischemic Stroke. Phase 1/Phase 2
Terminated NCT00132509 - FRALYSE Trial: Comparison of the Classical Rt-PA Procedure With a Longer Procedure in Acute Ischemic Stroke Phase 2
Recruiting NCT05760326 - Diagnostic and Prognostic Role of Clot Analysis in Stroke Patients